XyloCor Therapeutics, Inc.

📍 Wayne, United States🗓 Founded 2013👥 18 employees💰 Last funded Jan 2021
Research Services🌐 xylocor.com
Website LinkedIn
XyloCor Therapeutics is a development-stage, biotechnology company dedicated to developing first-in-class gene therapies for patients with unmet medical need in cardiovascular disease.
2
Total investors
0
Early stage
1
Mid stage
1
Late stage
2013
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
United States
1
Netherlands
1
Frequently asked questions
Who invested in XyloCor Therapeutics, Inc.?
XyloCor Therapeutics, Inc. has 2 investors on record on gritt.io, 1 mid-stage and 1 late-stage investors.
When did XyloCor Therapeutics, Inc. last raise funding?
The most recent investment in XyloCor Therapeutics, Inc. recorded on gritt.io was in January 2021.
When was XyloCor Therapeutics, Inc. founded?
XyloCor Therapeutics, Inc. was founded in 2013.
What industry is XyloCor Therapeutics, Inc. in?
XyloCor Therapeutics, Inc. operates in Research Services. Find similar Research Services investors on gritt.io.
Where is XyloCor Therapeutics, Inc. based?
XyloCor Therapeutics, Inc. is headquartered in Wayne, United States.